Viro - viro - Ravimiamet

kimball electronics, inc. - naloksoon - süstelahus eeltäidetud süstevahendis - 10mg 0.4ml 0.4ml 10tk

Viro - viro - Ravimiamet

accord healthcare b.v. - beetahistiin - tablett - 24mg 90tk; 24mg 20tk; 24mg 60tk; 24mg 84tk; 24mg 50tk; 24mg 100tk

Euroopan unioni - viro - EMA (European Medicines Agency)

novartis europharm limited - brinsolamiidi, brimonidine tartraat - ocular hypertension; glaucoma, open-angle - oftalmoloogilised vahendid - kõrge silmasisese rõhu (iop) vähenemine avatud nurga glaukoomi või okulaarse hüpertensiooniga täiskasvanud patsientidel, kellel monoteraapia annab iop-i vähesuse.

Viro - viro - Ravimiamet

baxter healthcare limited - naatriumkloriid - infusioonilahus - 0,9% 50ml 50tk; 0,9% 1000ml 10tk; 0,9% 50ml 1tk; 0,9% 100ml 1tk; 0,9% 250ml 1tk; 0,9% 500ml 1tk

Euroopan unioni - viro - EMA (European Medicines Agency)

laboratoires delbert - histamiini dihüdrokloriid - leukeemia, müeloidne, äge - immunostimulants, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). ceplene efektiivsus ei ole täielikult tõestatud üle 60-aastastel patsientidel.

Viro - viro - Ravimiamet

accord healthcare b.v. - donepesiil - õhukese polümeerikattega tablett - 5mg 98tk; 5mg 10tk; 5mg 50tk; 5mg 30tk; 5mg 120tk; 5mg 28tk; 5mg 84tk; 5mg 7tk; 5mg 56tk

Viro - viro - Ravimiamet

accord healthcare b.v. - donepesiil - õhukese polümeerikattega tablett - 10mg 60tk; 10mg 30tk; 10mg 98tk; 10mg 120tk; 10mg 100tk; 10mg 7tk; 10mg 28tk; 10mg 84tk

Euroopan unioni - viro - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Euroopan unioni - viro - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.